Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, efficacy and dose-response of AGN-210669. This study
will also compare AGN-210669 with bimatoprost ophthalmic solution (LUMIGAN®).